Top Research Papers on Vaping

This comprehensive review discusses the diverse spectrum of vaping exposures, epidemiological and clinical reports, and experimental findings to provide a better understanding of EVALI and the adverse health effects of chronic e-cigarette exposure.

Although research remains somewhat equivocal, there is clear reason for concern regarding the potential oncogenicity of E-Cigarettes/E-Liquids with a strong basic and molecular science basis.

Until more is known about the health effects of vaping, individual factors that need to be taken into consideration include age, current and prior use of combustible tobacco products, and whether the user has preexisting lung conditions such as asthma and chronic obstructive pulmonary disease (COPD).

JUUL’s peak nicotine levels were half to three-quarters that of a combustible cigarette in industry-conducted studies with JUUL-naïve users, while comparable to or greater than combustible cigarettes in independent studies of experienced e-cigarette users.

Data from both humans and animal models are consistent in demonstrating that vaping of e‐cigarettes causes health effects both similar to and disparate from those of cigarette smoking.

This review article aims to describe e-cigarette or vaping-product associated lung injury, its pathogenesis, clinical, radiological manifestations and management.

This review examines the known and suspected toxicity of electronic cigarettes (e-cigarettes) in adolescents and young adults to improve awareness of risks and identification of complications of their use, and calls for physicians to be cognizant of this expanding epidemic.

Increase in perceived accessibility of some vaping products, as well as increases in perceived risk of nicotine vaping, occurred from 2019 to 2020, yet, adolescent nicotine vaping remains highly prevalent, flavors remain highly accessible, and declines in JUUL use were countered by increased use of other brands.

A combined analytical, theoretical, and experimental study has shown that the vaping of vitamin E acetate has the potential to produce exceptionally toxic ketene gas, which may be a contributing factor to the upsurge in pulmonary injuries associated with using e-cigarette/vaping products.

New emerging tobacco products, especially electronic cigarettes (E-Cig) or electronic nicotine delivery systems (ENDS), have gained a huge popularity, particularly in younger populations. The lack of sufficient evidence-based health effect studies has promoted widespread use/abuse with the assumption that E-Cig or ENDS and/or vaping products are safer and less toxic than conventional tobacco smoking. However, the recent escalation in acute lung injuries and their associated fatalities among ENDS or vaping product users has now brought attention to this silent epidemic via investigation into th...

This randomized clinical trial determines the effectiveness of a text message program for vaping cessation among young adults aged 18 to 24 years vs assessment-only control.

It is timely, therefore, to review the short-term and especially the long-term implications of e-cigarettes and vaping products on cardiopulmonary health.

This cohort study examines rates of vaping and smoking among youths aged 16 to 19 years in the United States, Canada, and England from 2017 to 2019.

Salt vs free-base nicotine formulations resulted in statistically significant higher ratings of appeal, sweetness, and smoothness, and lower ratings of bitterness and harshness.

Youth EC use is associated with greater mental health problems across several domains, particularly among adolescents, and well-designed longitudinal studies to investigate long-term mental health sequalae of EC use remain needed.

While most EVALI patients were hospitalized, treatment remains largely supportive, and use of corticosteroids has been associated with clinical improvement, and the need for regulation of e-cigarette devices and e-liquids is highlighted.

Young people trying to quit e-cigarettes are motivated by a diversity of reasons including health, financial, social, and academic, which should be considered in discussions of policies intended to protect young people, and incorporated into cessation programs designed to serve them.

Analysis of vaporizer cartridges recovered from patients with EVALI found VEA and squalane are components of some personal care products; however, there is growing concern that vaping large amounts of these compounds is not safe.

Since August 2019, CDC, the Food and Drug Administration (FDA), state and local health departments, and public health and clinical stakeholders have been investigating a nationwide outbreak of e-cigarette, or vaping, product use-associated lung injury (EVALI) (1). This report updates patient demographic characteristics, self-reported substance use, and hospitalization dates for EVALI patients reported to CDC by states, as well as the distribution of emergency department (ED) visits related to e-cigarette, or vaping, products analyzed through the National Syndromic Surveillance Program (NSSP). ...

The authors summarize the current state of the art for the imaging and pathologic findings of this disorder and outline a few of the major questions that remain to be answered.

Use of disposable e-cigarettes in Great Britain grew rapidly between 2021 and 2022, especially among younger adults, but the overall prevalence of inhaled nicotine use -- smoked or vaped -- was stable over time.

The workshop identified the need to address the root causes of EVALI to prevent future outbreaks and identify critical needs for research and regulatory needs to adequately respond to the EVALi outbreak.